NanoViricides
NNVCInstitutional ownership · Q2 2026
Institutional holders
47
Unchanged vs Q1 2026
Reported value
$3.3M
+88.9% vs Q1 2026
Shares held
2.4M
+471.4K shares
Quarter
Q2 2026
Period ended Jun 30, 2026
47 institutional managers reported holding 2,371,449 shares worth $3,272,505 on Form 13F for Q2 2026, against 47 in Q1 2026. Share positions on CUSIP 630087953 only; option legs and principal-amount lines are not counted.
Top 25 institutional holders · Q2 2026
| # | Manager | Shares | Value | % of portfolio | Change | Position page |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 919,313 | $1.3M | < 0.01% | +407.8K | Position |
| 2 | GEODE CAPITAL MANAGEMENT LLC | 216,022 | $298.2K | < 0.01% | -9.4K | Position |
| 3 | Connective Capital Management LLC | 185,217 | $255.6K | 0.18% | New | Position |
| 4 | BlackRock Inc | 158,752 | $219.1K | < 0.01% | — | Position |
| 5 | VANGUARD FIDUCIARY TRUST CO | 131,923 | $182.1K | < 0.01% | +41.9K | Position |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 128,600 | $177.5K | < 0.01% | -6.3K | Position |
| 7 | Miller Financial Services LLC | 112,000 | $154.6K | 0.12% | +7.0K | Position |
| 8 | UBS Group AG | 99,331 | $137.1K | < 0.01% | -114.0K | Position |
| 9 | Creative Planning | 86,761 | $119.7K | < 0.01% | New | Position |
| 10 | SUSQUEHANNA INTERNATIONAL GROUP LLP | 60,616 | $83.7K | < 0.01% | -38.4K | Position |
| 11 | STATE STREET CORPORATION | 54,206 | $74.8K | < 0.01% | — | Position |
| 12 | NORTHERN TRUST CORPORATION | 51,265 | $70.7K | < 0.01% | +27.0K | Position |
| 13 | BRIDGEWAY CAPITAL MANAGEMENT LLC | 36,039 | $49.7K | < 0.01% | — | Position |
| 14 | Moss Adams Wealth Advisors LLC | 21,500 | $29.7K | < 0.01% | — | Position |
| 15 | Wharton Business Group LLC | 15,736 | $21.7K | < 0.01% | — | Position |
| 16 | TWO SIGMA SECURITIES LLC | 13,816 | $19.1K | < 0.01% | New | Position |
| 17 | Foundations Investment Advisors LLC | 10,105 | $13.9K | < 0.01% | +100 | Position |
| 18 | TRUE Private Wealth Advisors | 10,000 | $13.8K | < 0.01% | — | Position |
| 19 | Sandy Cove Advisors LLC | 10,000 | $13.8K | < 0.01% | — | Position |
| 20 | ADVISOR GROUP HOLDINGS INC | 9,350 | $12.9K | < 0.01% | +1.7K | Position |
| 21 | BankPlus Trust Department | 7,000 | $9.7K | < 0.01% | — | Position |
| 22 | EFG International AG | 4,500 | $6.2K | < 0.01% | — | Position |
| 23 | NBC SECURITIES INC | 4,400 | $6.1K | < 0.01% | +1.0K | Position |
| 24 | Vanguard Global Advisers LLC | 3,712 | $5.1K | < 0.01% | — | Position |
| 25 | Tower Research Capital LLC TRC | 3,642 | $5.0K | < 0.01% | -3.3K | Position |
Values as reported on each manager's Q2 2026 Form 13F. Change is in shares against the manager's prior-quarter filing.
13F holders by quarter
| Quarter | Holders | Shares | Value |
|---|---|---|---|
| Q2 2026 | 47 | 2.4M | $3.3M |
| Q1 2026 | 47 +5 | 1.9M | $1.7M |
| Q4 2025 | 42 +7 | 3.1M | $3.5M |
| Q3 2025 | 35 +2 | 1.4M | $2.0M |
| Q2 2025 | 33 -4 | 1.3M | $1.9M |
| Q1 2025 | 37 +2 | 1.5M | $1.7M |
| Q4 2024 | 35 +3 | 1.5M | $2.1M |
| Q3 2024 | 32 -2 | 1.3M | $2.0M |
| Q2 2024 | 34 +5 | 1.3M | $2.3M |
| Q1 2024 | 29 -2 | 1.2M | $1.4M |
| Q4 2023 | 31 +1 | 1.2M | $1.2M |
| Q3 2023 | 30 +3 | 1.2M | $1.6M |
| Q2 2023 | 27 -3 | 1.2M | $1.4M |
| Q1 2023 | 30 | 1.3M | $1.5M |
| Q4 2022 | 30 +2 | 1.4M | $1.5M |
| Q3 2022 | 28 +6 | 1.3M | $2.3M |
| Q2 2022 | 22 -2 | 1.1M | $2.1M |
| Q1 2022 | 24 -2 | 1.2M | $2.4M |
| Q4 2021 | 26 -3 | 1.1M | $4.1M |
| Q3 2021 | 29 | 957.0K | $4.4M |
Q3 2021–Q2 2026, as reported on Form 13F. Earlier quarters are in the ownership explorer below.
Across other SEC filings
Insiders · Form 4
No open-market purchases or sales by NanoViricides insiders in the last 12 months.
Latest filings
- Milton Boniuk 2025-01-28 -
- Stephenson Fournier, PLLC 2025-01-24 -
- Anil Diwan 2022-08-10 Gift/Other
Annual & quarterly reports
-
10-K · FY2026 Filed 2026-09-28Business · Risk Factors · Management's Discussion and Analysis
Ownership explorer
Loading ownership explorer…
Security Details
| CUSIP | 630087953 |
|---|---|
| Symbol | NNVC |
| Type | Common stock |
| Class | COM as filed on 13F |
| Exchange | NYSE |
| Company | NanoViricides |
Other securities from this issuer
| Name | Symbol | CUSIP | Type |
|---|---|---|---|
| NANO VIRCIDES INC | NNVC | 630087104 | Common stock |
| NANOVIRICIDES INC | NNVC | 630087302 | Common stock |
| NANOVIRICIDES INC NEW COMMON | NNVC | 630087203 | Common stock |
Identifier History
| Type | Value | From | To |
|---|---|---|---|
| CUSIP | 630087953 | 2013-12-31 | Current |
Listing History
| Symbol | Exchange | From | To |
|---|---|---|---|
| NNVC | NYSE | 2026-02-19 | Current |